⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMDX News
Insight Molecular Diagnostics Inc. Common Stock
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
globenewswire.com
IMDX
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
globenewswire.com
IMDX
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
globenewswire.com
IMDX
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
globenewswire.com
IMDX
Form 8-K
sec.gov
IMDX
iMDx Announces $26.0 Million Registered Direct Offering
globenewswire.com
IMDX
IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring
globenewswire.com
IMDX
iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation
globenewswire.com
IMDX
iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch
globenewswire.com
IMDX
iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion
globenewswire.com
IMDX
BIO